Prospective Evaluation of the Efficacy of Palivizumab Administration in Children Born at 29-32 Weeks of Gestation
Clinical trial NCT01269528 · COMPLETED
Trial details
- NCT number
- NCT01269528
- Sponsor
- Rambam Health Care Campus
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2013-08-01
- Primary completion
- 2015-08-01
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.